相关实验视频
Updated: May 17, 2025

07:07
Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice
Published on: January 7, 2019
6.0K
在慢性阻塞性肺病中识别氧化压力相关的生物标志物:综合生物信息学分析
Xianwei Jiang1,2, Minghang Wang1,2,3, Huiru Li1,2
1National Regional TCM (Lung Disease) Diagnostic and Treatment Center, The First Affiliated Hospital of Henan University of CM, Zhengzhou, People's Republic of China.
概括
这项研究确定了五个关键的氧化压力相关基因作为诊断慢性阻塞性肺病 (COPD) 的潜在生物标志物. 这些发现为COPD提供了新的治疗目标和药物开发方向.
科学领域:
- 基因组学就是基因组学.
- 生物标志物发现发现
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性阻塞性肺病 (COPD) 是全球主要的死亡原因,患病率越来越高.
- 氧化应激 (OS) 在COPD的发病过程中起着至关重要的作用,因此需要识别与OS相关的生物标志物,以改善诊断和治疗.
- 目前对COPD的诊断和治疗策略需要通过新生物标志物识别来加强.
研究的目的:
- 确定与COPD相关的新型氧化压力相关基因 (OSRGs).
- 选核心基因,可以作为COPD的诊断生物标志物.
- 基于已识别的基因,探索潜在的治疗点和COPD治疗药物.
主要方法:
- 利用基因表达综合数据库用于COPD患者的遗传数据.
- 进行了功能丰富分析 (KEGG,GO) 并构建了蛋白质-蛋白质相互作用网络以确定核心的OSRG.
- 使用接收器操作特征 (ROC) 曲线验证了核心基因,并开发了一个诊断模型.
- 分析了基因与免疫细胞的相关性,预测了向药物,并确定了调节性miRNA和转录因子 (TF).
主要成果:
- 确定了299个差异性基因,包括16个OSRG,其中五个核心基因 (HSPA1A,GCL-M,IL-1β,ICAM1,GCLC) 已被验证为潜在的诊断生物标志物.
- 功能丰富分析突出了OS响应和亡信号通路中的作用.
- 基于五个核心基因的诊断模型实现了0.981.91的曲线下的面积.
- 预测了33种潜在的向药物,并确定了涉及33种miRNA和38种TF的监管网络.
结论:
- 已识别的五个核心基因 (HSPA1A,GCL-M,IL-1β,ICAM1,GCLC) 显示出作为COPD诊断生物标志物的希望.
- 这项研究为COPD管理中药物开发提供了新的潜在治疗目标和方向.
- 这项研究有助于更好地了解COPD和氧化应激背后的分子机制.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K

